Classification of deficiencies MCQs With Answer

Introduction: Classification of deficiencies MCQs With Answer is designed for M.Pharm students to deepen their understanding of how regulatory authorities categorise findings observed during audits and inspections. This set of questions focuses on the principles used to classify deficiencies—such as critical, major, and minor—along with examples, risk-based rationale, and the regulatory consequences that follow. Emphasis is placed on linking deficiency severity to patient safety, product quality, and system robustness. Practicing these MCQs will help students refine their audit judgement, interpret inspection observations, and prepare appropriate corrective actions and regulatory responses in a pharmaceutical quality environment.

Q1. Which of the following best defines a “critical” deficiency in a regulatory inspection?

  • A finding that indicates a documented procedure is missing but with no immediate impact on product quality
  • A deviation that could lead to significant harm to patient safety or product sterility if not corrected
  • A minor paperwork error in batch records
  • An isolated deviation in labeling with no distribution

Correct Answer: A deviation that could lead to significant harm to patient safety or product sterility if not corrected

Q2. Which classification is most appropriate for a repeated failure of environmental monitoring leading to out-of-specification microbial counts?

  • Minor
  • Administrative
  • Major
  • Cosmetic

Correct Answer: Major

Q3. In EU GMP terms, which category typically corresponds to an observation that does not pose an immediate risk but indicates systemic gaps requiring corrective actions?

  • Critical
  • Major
  • Minor
  • Immediate recall

Correct Answer: Major

Q4. Which of the following examples best represents a “minor” deficiency?

  • Absence of validated aseptic process for sterile product manufacture
  • Label printing batch number misalignment on a few retained samples
  • Product contamination resulting in patient harm
  • Systemic failure to investigate OOS results

Correct Answer: Label printing batch number misalignment on a few retained samples

Q5. How do regulatory agencies commonly differentiate between “repeat” and “systemic” deficiencies?

  • Repeat means the same inspector raised it twice in one inspection; systemic means it appears in the final report
  • Repeat indicates recurrence of a previous finding; systemic indicates a root-cause that affects multiple systems or processes
  • Repeat refers to duplicative records; systemic refers to a single isolated event
  • They are synonyms and used interchangeably by regulators

Correct Answer: Repeat indicates recurrence of a previous finding; systemic indicates a root-cause that affects multiple systems or processes

Q6. Which factor is most important when classifying the severity of an inspection finding?

  • The position of the person who discovered it
  • The potential impact on patient safety and product quality
  • The age of the batch records involved
  • The frequency of inspections at the site

Correct Answer: The potential impact on patient safety and product quality

Q7. A process validation report shows incomplete data analysis but no evidence of OOS product release. Which classification is most appropriate?

  • Critical
  • Major
  • Minor
  • No observation

Correct Answer: Major

Q8. Which regulatory action usually follows multiple critical findings at a manufacturing site?

  • Issuance of a voluntary advisory note with no follow-up
  • Immediate site closure, product seizure, or legal enforcement
  • Invitation to a public conference
  • Simple request to update company logo

Correct Answer: Immediate site closure, product seizure, or legal enforcement

Q9. Which of the following best describes an “observation” on an FDA Form 483 in terms of classification?

  • All Form 483 items are legally binding recalls
  • Form 483 items are observations that can be critical, major, or minor based on context
  • Form 483 only lists minor administrative comments
  • Form 483 is used solely to approve new drug applications

Correct Answer: Form 483 items are observations that can be critical, major, or minor based on context

Q10. Which example is most likely to be classified as a “major” deficiency related to laboratory controls?

  • Temporary absence of a pen used for signing records
  • Failure to retest OOS results and document investigations
  • Minor formatting error in a test report header
  • Using two different colors of labels in a storage area

Correct Answer: Failure to retest OOS results and document investigations

Q11. When auditors classify deficiencies based on risk, which methodology is commonly used to combine severity and likelihood?

  • Random selection
  • Risk matrix (severity x probability)
  • Alphabetical ordering
  • Counting pages in the SOP

Correct Answer: Risk matrix (severity x probability)

Q12. Which classification would be appropriate for finding that a critical equipment calibration was not performed for several months and results are undocumented?

  • Minor
  • Major
  • Trivial
  • Non-applicable

Correct Answer: Major

Q13. In a regulatory context, which deficiency characteristic most often elevates a finding from “major” to “critical”?

  • Presence of a typo in the procedure title
  • Direct evidence of patient harm or confirmed contaminated distributed product
  • Use of outdated paper forms
  • Minor delay in training schedule

Correct Answer: Direct evidence of patient harm or confirmed contaminated distributed product

Q14. How should a firm classify a deficiency when a manufacturing step that controls a Critical Quality Attribute (CQA) is missing validation?

  • Minor, because documentation is the only issue
  • Major or critical depending on the CQA’s impact on patient safety
  • Administrative
  • Irrelevant to classification

Correct Answer: Major or critical depending on the CQA’s impact on patient safety

Q15. Which of the following is a common regulatory consequence for a site with persistent major deficiencies and insufficient CAPA?

  • Increase in advertising budget
  • Placement on official watch lists, import alerts, or issuance of warning letters
  • Automatic product approval
  • Award for best practices

Correct Answer: Placement on official watch lists, import alerts, or issuance of warning letters

Q16. A documentation lapse where training records are incomplete for a small non-GMP administrative group should be classified as:

  • Critical
  • Major
  • Minor
  • Product recall

Correct Answer: Minor

Q17. Which factor makes an observation more likely to be classified as “systemic” rather than “isolated”?

  • It occurred only once in a temporary contractor file
  • Multiple departments show the same root cause and similar failures
  • It is documented in a single archived memo
  • It concerns office stationery

Correct Answer: Multiple departments show the same root cause and similar failures

Q18. During classification, why is traceability and historical evidence reviewed to escalate or de-escalate a finding?

  • To prove inspectors were wrong
  • To determine recurrence, duration and potential product impact which affect severity
  • To increase paperwork volume
  • Because auditors prefer longer reports

Correct Answer: To determine recurrence, duration and potential product impact which affect severity

Q19. Which of the following best describes a correctly prioritized CAPA when addressing a critical deficiency?

  • Focus only on cosmetic fixes to records
  • Immediate containment, root cause analysis, risk assessment and systemic corrective actions
  • Delay action pending next routine audit
  • Outsource responsibility without oversight

Correct Answer: Immediate containment, root cause analysis, risk assessment and systemic corrective actions

Q20. In inspection reports, why might an inspector classify a labeling omission as “major” rather than “minor”?

  • Because any labeling omission always triggers product destruction
  • When the omission could cause misadministration or incorrect dosing affecting patient safety
  • Labeling omissions are never considered by inspectors
  • Because the inspector dislikes the label design

Correct Answer: When the omission could cause misadministration or incorrect dosing affecting patient safety

Author

  • G S Sachin Author Pharmacy Freak
    : Author

    G S Sachin is a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. He holds a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research and creates clear, accurate educational content on pharmacology, drug mechanisms of action, pharmacist learning, and GPAT exam preparation.

    Mail- Sachin@pharmacyfreak.com

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators